Crispr Therapeutics shares owned by Saturna Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Saturna Capital
from 13F filings
Historical chart of Saturna Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Saturna Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Saturna Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $459k | 9.8k | 46.98 |
| 2024-06-30 | $528k | 9.8k | 54.01 |
| 2024-03-31 | $745k | 11k | 68.16 |
| 2023-12-31 | $684k | 11k | 62.60 |
| 2023-06-30 | $210k | 3.7k | 56.14 |
| 2021-09-30 | $210k | 1.9k | 111.70 |
| 2021-06-30 | $288k | 1.8k | 161.80 |
| 2020-12-31 | $2.0M | 13k | 153.08 |
| 2020-09-30 | $1.2M | 14k | 83.66 |
| 2020-06-30 | $1.0M | 14k | 73.52 |
| 2019-12-31 | $207k | 3.4k | 60.88 |